Navigation Links
WAVi Co. Announces Collaborative Agreement with SomaLogic, Inc.
Date:8/1/2011

BOULDER, Colo., Aug. 1, 2011 /PRNewswire-iReach/ -- WAVi Co. announced today it has entered into a collaboration agreement with SomaLogic, Inc. Under the agreement, WAVi will apply its unique bioinformatics expertise to SomaLogic's proprietary proteomic assays for an undisclosed fee. In addition, the companies agree to work together to plan two clinical research studies in dementia that will combine WAVi's EEG (electroencephalogram)-based biomarkers and SomaLogic's blood-based protein biomarkers.

"This collaboration with SomaLogic validates both our world-class bioinformatics capabilities as well as the potential of WAVi's brain assessment platform – a platform designed as a point of care, rapid screening device providing an objective and accurate measurement to aid in the early detection and diagnosis of cognitive ailments and other neurological disorders," said Stephen K. Onody, President and CEO of WAVi. "Our mission is pre-symptomatic detection leading to early diagnosis enabling timely treatmentof cognitive ailments. Dementia costs the U.S. $183 billion per year and it is estimated that 1 in 8 people will develop Alzheimer's.  The WAVi system is designed to assist physicians to ensure patients are treated or referred to specialist care when need exists."

Larry Gold, PhD, SomaLogic Chief Executive Officer added "We are delighted to begin this collaboration with WAVi, and believe that our unique contributions to our joint work will speed the early detection and diagnosis not just of dementia but many different human diseases, offering the possibility for earlier and more effective therapeutic interventions."

About WAVi Co.

WAVi Co. (www.ewavi.com) is a privately held, medical technology company developing the first simple to use, low-cost, EEG brain assessment platform suitable for mass screening.  The WAVi device is designed to determine deviation from norm utilizing a normative database and/or self-comparison to aid in early detection and diagnosis of cognitive ailments and other neurological disorders.

CAUTION: THE WAVi SYSTEM IS AN INVESTIGATIONAL DEVICE, LIMITED BY FEDERAL (UNITED STATES) LAW TO INVESTIGATIONAL USE.

About SomaLogic

SomaLogic, Inc., is a privately held biomarker discovery and clinical proteomics company based in Boulder, Colorado. The company's mission is to use its proprietary Slow-Offrate Modified Aptamer ("SOMAmer") technology to develop enhanced protein analysis tools and reagents for the life sciences community, to facilitate target validation, and to develop and commercialize clinical diagnostic products that will improve the delivery of healthcare by offering timely and accurate diagnostic information to physicians and their patients. Further information about SomaLogic can be found at www.somalogic.com.

Media Contact: Stephen Onody WAVi Co., 720-542-3855, steveo@ewavi.com


'/>"/>
SOURCE WAVi Co.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
2. International Isotopes Inc. Announces Successful International Standards Certification for Manufacture of Its Nuclear Medicine Products and Devices
3. Biocept, Inc. Announces Availability of Its New Breast Cancer Test, OncoCEE-BR™ Utilizing Circulating Tumor Cells (CTCs)
4. TriLink BioTechnologies, Inc. Announces License Agreement with Lucigen Corporation
5. Verenium Announces Debt Repurchase
6. Life Technologies Announces Second Quarter 2011 Results
7. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study
8. Dyadic International Announces Date of Second Quarter 2011 Financial Results Release and Conference Call
9. MiMedx Group Announces Second Quarter 2011 Results
10. BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study
11. ADVENTRX Announces Appointment of Senior Vice President, Commercial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2017)... Raleigh, NC (PRWEB) , ... June 21, 2017 ... ... solutions for attracting and hiring top executive talent in the life sciences industry, ... Development and Manufacturing company. The partnership takes full advantage of Beaker’s expertise ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... network RegMedNet has produced a Spotlight series on “Cell ... reviews and perspectives by leading experts on the unique regulatory challenges of stem ...
(Date:6/20/2017)... CT (PRWEB) , ... June 20, 2017 , ... ... today announced that the CTNext board of directors has formed a Higher Education ... a working group composed of institution presidents and other high-ranking representatives from 35 ...
(Date:6/20/2017)... , ... June 20, 2017 , ... Do More with ... transition from being a trusted supplier in the weighing industry, to extending its expertise ... ELISA essays, enzyme reactions, immunoassays, hybridizations and more, allowing for its customers ...
Breaking Biology Technology:
(Date:5/6/2017)... , May 5, 2017 ... just announced a new breakthrough in biometric authentication ... exploits quantum mechanical properties to perform biometric authentication. These ... smart semiconductor material created by Ram Group and ... finance, entertainment, transportation, supply chains and security. Ram ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... Report on Form 10-K on Thursday April 13, 2017 with the ... The ... section of the Company,s website at http://www.nxt-id.com  under "SEC Filings," ... 2016 Year Highlights: Acquisition of ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Biology News(10 mins):